Newly identified pathway could lead to obesity treatments
30 June 2016 | By Victoria White, Digital Content Producer
Scientists identified a natural molecular pathway that enables cells to burn off calories as heat rather than store them as fat...
List view / Grid view
News
Zika virus vaccine prevents viral replication in mice
30 June 2016 | By Victoria White, Digital Content Producer
An experimental vaccine against Zika virus has been tested successfully in trials with mice, giving 100% protection...
Probiodrug and Crossbeta team up for Alzheimer’s disease biomarkers
30 June 2016 | By Victoria White, Digital Content Producer
The partnership will allow Probiodrug to utilise Crossbeta’s proprietary technology in support of Probiodrug’s biomarker development activities...
Proteogenomics provides new inroads to ovarian cancer treatments
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have examined the proteomes of 169 ovarian cancer patients to identify critical proteins expressed by their tumours...
MSD and Moderna to develop personalised cancer vaccines
29 June 2016 | By Victoria White, Digital Content Producer
Moderna and MSD will develop personalised cancer vaccines that utilise Moderna’s mRNA vaccine technology to encode a patient’s specific neoantigens...
Small doses of anti-HIV drug efavirenz might treat Alzheimer’s
29 June 2016 | By Victoria White, Digital Content Producer
A study suggests efavirenz might be an effective therapy for stimulating cholesterol turnover from the brain and slowing or preventing Alzheimer's disease...
Scientists stabilise HIV structure and design potential vaccine candidates
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have described a strategy to stabilise an important HIV structure and potentially create HIV lookalikes for large-scale vaccine production...
Heptares and leadXpro to employ powerful new techniques for GPCR structure determination
29 June 2016 | By Victoria White, Digital Content Producer
Heptares Therapeutics and leadXpro are to employ powerful new approaches for the determination of high-resolution X-ray structures of GPCRs...
Nordic Nanovector and AREVA to investigate lead-212 for leukaemia
28 June 2016 | By Victoria White, Digital Content Producer
Nordic Nanovector and AREVA Med have entered into a collaboration agreement to investigate the potential of a 212Pb-conjugated anti-CD37 antibodies...
Storm Therapeutics secures £12 million in series A funding
28 June 2016 | By Victoria White, Digital Content Producer
Storm Therapeutics has secured £12 million in series A funding to identify small molecular drugs that target RNA-modifying enzymes...
Potential new drug target for polycystic kidney disease
28 June 2016 | By Victoria White, Digital Content Producer
Researchers have used virtual tissue technology to identify a potential new drug target in the fight against polycystic kidney disease...
Anthrax toxin protein regimen shows promise in treating cancerous tumours
28 June 2016 | By Victoria White, Digital Content Producer
Combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumours...
Discovery could lead to new and better heart failure drugs
27 June 2016 | By Victoria White, Digital Content Producer
Research offers the possibility of developing a new class of heart failure medications that could potentially be more effective than existing treatments...
GlyRS identified as a possible new breast cancer drug target
27 June 2016 | By Victoria White, Digital Content Producer
Scientists have identified a protein, called GlyRS, that launches cancer growth and appears to contribute to higher mortality in breast cancer patients...
ESCMID-ASM to review antimicrobial development process
27 June 2016 | By European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
ESCMID and ASM are jointly organising a conference to help researchers accelerate the development of new antimicrobials for drug-resistant infections...